CS logo
small CS logo
Abington Neurological Associates

Abington, Pennsylvania, United States
Medical clinic in Abington, Pennsylvania
1151 Old York Rd Suite 200, Abington, PA 19001

About Abington Neurological Associates


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Abington Neurological Associates


During the past decade, Abington Neurological Associates conducted 55 clinical trials. In the 10-year time frame, 55 clinical trials started and 30 clinical trials were completed, i.e. on average, 54.5% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 17 clinical trials were completed. i.e. 70.8% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Preventive Treatment Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection
1999-09-01
Completed
2,000
A Pilot Study Evaluating Penicillin G and Ceftriaxone as Therapies for Presumed Neurosyphilis in HIV Seropositive Individuals
1996-02-01
Completed
100
A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT)
2007-08-01
Completed
1,600
Preventing Frequent Sinus Infections in HIV-Infected Patients
1993-02-01
Withdrawn
0
A Comparative Study of a Combination of Zidovudine, Didanosine, and Double-Blinded Nevirapine Versus a Combination of Zidovudine and Didanosine
1994-11-01
Completed
400
A Randomized, Double-Blind, Four-Arm Study Comparing Combination Nucleoside, Alternating Nucleoside, and Triple-Drug Therapy for the Treatment of Advanced HIV Disease (CD4 <= 50/mm3)
1996-09-01
Completed
1,292
Thalidomide for Treatment of Oral and Esophageal Aphthous Ulcers and HIV Viremia in Patients With HIV Infection
1998-10-01
Completed
164
A Study of Indinavir Sulfate Plus Zidovudine (AZT) Plus Lamivudine in HIV-Infected Patients Who Have Taken AZT for Six or More Months
1997-06-01
Completed
1,750

Rows per page:

1–100 of 594

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Abington Neurological Associates" #1 sponsor was "Hoffmann-La Roche" with 13 trials, followed by "Eli Lilly and Company" with 10 trials sponsored, "Pfizer" with 4 trials sponsored, "Allergan" with 3 trials sponsored and "Genentech, Inc." with 3 trials sponsored. Other sponsors include 32 different institutions and companies that sponsored additional 33 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Abington Neurological Associates" #1 collaborator was "National Institute on Aging (NIA)" with 7 trials as a collaborator, "Alzheimer's Disease Cooperative Study (ADCS)" with 3 trials as a collaborator, "Pfizer" with 3 trials as a collaborator, "Alzheimer's Clinical Trials Consortium" with 2 trials as a collaborator and "AbbVie" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Abington Neurological Associates


According to Clinical.Site data, the most researched conditions in "Abington Neurological Associates" are "Alzheimer Disease" (20 trials), "Alzheimer's Disease" (14 trials), "Dementia" (4 trials), "Multiple Sclerosis" (4 trials) and "Alzheimers Disease" (3 trials). Many other conditions were trialed in "Abington Neurological Associates" in a lesser frequency.

Clinical Trials Intervention Types at Abington Neurological Associates


Most popular intervention types in "Abington Neurological Associates" are "Drug" (66 trials), "Other" (3 trials), "Biological" (2 trials), "Procedure" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (34 trials), "Gantenerumab" (4 trials), "Ocrelizumab" (4 trials), "Bapineuzumab 0.5 mg/kg" (3 trials) and "Crenezumab" (3 trials). Other intervention names were less common.

Clinical Trials Genders at Abington Neurological Associates


The vast majority of trials in "Abington Neurological Associates" are 70 trials for "All" genders.

Clinical Trials Status at Abington Neurological Associates


Currently, there are NaN active trials in "Abington Neurological Associates". undefined are not yet recruiting, 14 are recruiting, 9 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 24 completed trials in Abington Neurological Associates, 1 suspended trials, and 18 terminated clinical trials to date.
Out of the total trials that were conducted in Abington Neurological Associates, 3 "Phase 1" clinical trials were conducted, 23 "Phase 2" clinical trials and 43 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status